Clinical Trial: BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07160244) titled 'BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies' on Aug. 14.

Brief Summary: BEATRIX (group B strEptococcus mATeRnal and Infant VaX study) The purpose of this study is to learn about the safety and how the group B streptococcus (GBS) vaccine works in pregnant women and their babies.

This study is seeking healthy pregnant participants:

* aged 49 or younger who can join.

* between 24 and 36 weeks of gestation ("Gestational age" is a medical term used to describe how far along your pregnancy is)

* had a fetal ultrasound examination performed with no major fetal abnormalities...